摘要
随着诊断性腹腔镜的普及、晚期胃癌转化治疗概念的兴起,以及腹腔化疗港、腹腔热灌注化疗等技术的应用,胃癌腹膜转移的诊断与治疗取得新的进展。然而,胃癌腹膜转移预后差,治疗依旧缺乏高级别证据,在实践过程中应注意规范化诊断与评效,在患者筛选、手术指征、术后化疗等重要问题上进行多学科讨论决策。药物治疗的进展仍是未来提高胃癌腹膜转移预后的关键。
With the prevalence of diagnostic laparoscopy,the concept of conversion therapy in unresectable gastric cancer,as well as the technical application of port implantation and hyperthermic intraperitoneal chemotherapy,new progress has been made in the area of gastric cancer peritoneal metastasis.However,the prognosis for peritoneal metastasis of gastric cancer remains extremely poor,and surgical treatment still lacks high-level evidence.Surgeons should pay attention to standardized diagnosis and evaluation during medical practice,and should conduct multidisciplinary discussions on important issues,such as patient screening,surgical indications,and postoperative chemotherapy.The progress of drug therapy is still the key to improve the prognosis of gastric cancer peritoneal metastasis in the future.
作者
薛侃
李子禹
Kan Xue;Ziyu Li(Department of Gastrointestinal Surgery,Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China)
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2020年第3期114-117,共4页
Chinese Journal of Clinical Oncology
基金
吴阶平医学基金会临床科研专项资助项目(编号:320.2710.1811)资助。
关键词
胃癌
腹膜转移
外科
诊断
转化治疗
gastric cancer
peritoneal metastasis
surgery
diagnosis
conversion therapy